| 王永,宋秀荣,杜淑珍,李雅娟,周媛.尿激酶联合右旋糖苷治疗急性期脑梗死患者的效果及预后[J].中国临床保健杂志,2019,22(1):36-38. |
| 尿激酶联合右旋糖苷治疗急性期脑梗死患者的效果及预后 |
| Effect and prognosis of urokinase combined with dextrose in the treatment of acute cerebral infarction |
| 投稿时间：2018-03-01 |
| DOI：10.3969/J.issn.1672-6790.2019.01.011 |
| 中文关键词: 脑梗死 尿激酶型纤溶酶原激活物 颅内血栓形成 |
| 英文关键词: Brain infarction Urokinase-type plasminogen activator Intracranial thrombosis〖FL |
| 基金项目:内蒙古自治区包头市科技局科研立项项目(1300271693) |
|
| 摘要点击次数: 5969 |
| 全文下载次数: 4298 |
| 中文摘要: |
| 目的 分析尿激酶联合右旋糖苷治疗急性期脑梗死患者的临床疗效以及改善患者疾病预后价值。方法 将100例急性期脑梗死患者按照就诊单双号顺序分为观察组、对照组,每组50例。对照组使用丹参注射液治疗,以此为基础,观察组使用尿激酶联合右旋糖苷治疗,分析相关结果。结果 与对照组(76.00%)比较,观察组(96.00%)总有效率更高(χ2=10.714,P=0.001)。与对照组相比,观察组神经功能缺损下降明显(P＜0.05)。结论 尿激酶联合右旋糖苷治疗急性期脑梗死患者效果满意,并且改善预后。 |
| 英文摘要: |
| Objective To analyze the clinical efficacy of urokinase combined with dextrose in the treatment of acute cerebral infarction and to improve the prognosis of patients.Methods 100 patients with acute cerebral infarction were divided into the observation group and the control group according to the treatment order and the control group,50 cases in each group.The control group was treated with Salvia miltiorrhiza injection,and the observation group was treated with urokinase and dextran,and the results were analyzed.Results Compared with the control group (76.00%),the total effective rate of the observation group(96.00%) was higher (χ2=10.714,P=0.001).Compared with the control group,the neurological impairment of the observation group decreased significantly(P<0.05).Conclusion Urokinase combined with dextrose can be used for treating patients with acute cerebral infarction with satisfaction result. |
|
查看全文
|
| 关闭 |
|
|
|